Vagiannis, D., Novotna, E., Skarka, A., Kammerer, S., Küpper, J., Chen, S., . . . Hofman, J. (2020). Ensartinib (X-396) Effectively Modulates Pharmacokinetic Resistance Mediated by ABCB1 and ABCG2 Drug Efflux Transporters and CYP3A4 Biotransformation Enzyme. Cancers (Basel).

Vagiannis, Dimitrios, Eva Novotna, Adam Skarka, Sarah Kammerer, Jan-Heiner Küpper, Si Chen, Lei Guo, Frantisek Staud, et Jakub Hofman. "Ensartinib (X-396) Effectively Modulates Pharmacokinetic Resistance Mediated By ABCB1 and ABCG2 Drug Efflux Transporters and CYP3A4 Biotransformation Enzyme." Cancers (Basel) 2020.

Vagiannis, Dimitrios, et al. "Ensartinib (X-396) Effectively Modulates Pharmacokinetic Resistance Mediated By ABCB1 and ABCG2 Drug Efflux Transporters and CYP3A4 Biotransformation Enzyme." Cancers (Basel) 2020.